Publications by authors named "A J Wester"
Article Synopsis
- * The most commonly found PDMs were atypical enteropathogenic E. coli (16%), Yersinia enterocolitica (2%), and Shiga toxin-producing E. coli (1.7%), while other PDMs were less frequent.
- * Traveling outside Europe significantly increased the odds of carrying Campylobacter spp. and enterotoxigenic E. coli, while older individuals (≥65 years) were less likely to carry these microbes compared
Background And Aims: Timely transition of care amongst patients with a first diagnosis of cirrhosis in a hospital to an outpatient visit is important. We evaluated rates of outpatient follow-up after a first diagnosis of cirrhosis during an inpatient setting, and its association with subsequent rates of rehospitalisation and mortality.
Methods: We conducted a population-based cohort study identifying all hospitalised patients in Sweden diagnosed with cirrhosis between 2002 and 2020 from the Swedish National Patient Register.
Background And Aims: People living with human immunodeficiency virus (HIV) (PLWH) show a high incidence of chronic liver disease (CLD). However, whether HIV is associated with major adverse liver outcomes (MALO) in patients with underlying CLD remains to be determined.
Methods: In this population-based cohort study, data were retrieved from the Swedish National Patient Register to identify PLWH and CLD (n = 2375) or CLD without HIV (n = 144,346) between 1997 and 2020.
Article Synopsis
- * Researchers confirmed that the O1 isolates from these cases belonged to the seventh pandemic El Tor lineage (7PET) and identified virulence characteristics, antimicrobial resistance, and phylogenetic relationships among the strains.
- * The study found that 46 of 49 high-quality genomes belonged to the 7PET lineage, with a dominant subgroup likely contributing to the rise in cholera cases; it emphasized the need for whole genome sequencing in high-income countries to track the evolution of strains and antimicrobial resistance.
Background And Aims: The association between socioeconomic factors and disease severity is not well studied in people living with metabolic dysfunction-associated steatotic liver disease (MASLD). We thus examined if socioeconomic factors influence the presence of, or risk for future, major adverse liver outcomes (MALOs) in people living with MASLD.
Methods: We conducted a register-based cohort study that included all individuals with a MASLD diagnosis between 1987 and 2020 in Sweden.